Here's a rapid fire update on all 31 portfolio stocks including our newest name

Jim Cramer and Jeff Marks conducted their September portfolio review, outlining investment strategies for late 2025, considering macroeconomic factors like Federal Reserve policy and trade. The Club detailed specific rationales for holdings, including bullish views on Apple's iPhone 17 value and Amazon's margin expansion, initiating a new Boeing position based on trade policy, and taking profits in overweighted Broadcom. Other key insights highlighted growth catalysts for Capital One post-acquisition, CrowdStrike's ambitious revenue targets, and Wells Fargo's strategic shift following its asset cap removal. The review underscored a focus on long-term conviction in names like Eli Lilly and Meta Platforms, while addressing underperformance in others.

Analysis

The portfolio review reflects a bullish outlook for late 2025, contingent on navigating Federal Reserve policy and geopolitical trade factors. Conviction is highest in technology and AI-related sectors, with Nvidia's new partnership with Intel viewed as a significant move to defend its market leadership against AMD. This optimism extends to cybersecurity, where CrowdStrike's ambitious $20 billion annual recurring revenue (ARR) target reinforces its industry-leading status, and to AI infrastructure beneficiaries like Eaton and GE Vernova, positioned to capitalize on data center energy demand. In financials, specific catalysts are driving positive sentiment; Capital One is expected to see upside from its completed Discover acquisition and share repurchases, while Wells Fargo is poised for growth after the removal of its asset cap. The consumer sector shows a clear divergence, with TJX highlighted for its strongest-ever earnings period, while Home Depot is flagged for a potential trim due to a stalled housing market turnaround. The portfolio also includes strategic new positions, such as Boeing, which is projected to have the most multi-year upside based on favorable trade policies and a balance sheet recovery. Conversely, patience is advised for underperforming holdings like Bristol Myers Squibb, which is dependent on future clinical trial outcomes, and Disney, whose shares have stalled. A disciplined approach is evident with profit-taking in Broadcom after its portfolio weighting grew beyond 5%, while a hold-and-wait strategy is recommended for Salesforce ahead of its key conference.

Key Decisions for Investors

• Favor exposure to key AI beneficiaries like Nvidia, given its strengthening competitive moat, and infrastructure players such as Eaton and GE Vernova, which are set to profit from rising data center energy needs.
• Evaluate catalyst-driven financial stocks, particularly Capital One for post-acquisition synergies and Wells Fargo for its renewed growth potential following the removal of its long-standing asset cap.
• Differentiate within consumer discretionary, prioritizing companies with strong fundamental momentum like TJX Companies while reducing exposure to firms facing sector-specific headwinds, such as Home Depot's sensitivity to the housing market.
• Monitor event-driven stocks, including Bristol Myers Squibb for upcoming clinical trial data and DuPont for its planned Qnity Electronics spin-off, as these events could serve as significant re-rating catalysts.
• Employ disciplined portfolio management by considering trims on positions that have become overweight, like Broadcom, to manage concentration risk while maintaining conviction in long-term secular growth stories like Meta Platforms and Microsoft.